Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

29,769 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pulmonary Artery Denervation for Pulmonary Arterial Hypertension: A Sham-Controlled Randomized PADN-CFDA Trial.
Zhang H, Wei Y, Zhang C, Yang Z, Kan J, Gu H, Fan F, Gu H, Wang Q, Xie D, Zhang G, Guo X, Yin Y, Jin B, Zhou H, Yang Z, Wang Z, Xin Y, Zhang C, Meng L, Wang X, Sun J, Zhao C, Zhang J, Yan X, Chen F, Yao C, Stone GW, Chen SL. Zhang H, et al. Among authors: guo x. JACC Cardiovasc Interv. 2022 Dec 12;15(23):2412-2423. doi: 10.1016/j.jcin.2022.09.013. Epub 2022 Sep 18. JACC Cardiovasc Interv. 2022. PMID: 36121246 Free article. Clinical Trial.
Long-term mortality after pulmonary artery denervation stratified by baseline functional class in patients with pulmonary arterial hypertension: Long-term mortality after PADN stratified by functional class.
Zhang H, Kan J, Zhang C, Yang Z, Gu H, Fan F, Gu H, Wang Q, Zhang J, Xie D, Zhang G, Guo X, Yin Y, Chen SL. Zhang H, et al. Among authors: guo x. AsiaIntervention. 2022 Mar;8(1):58-68. doi: 10.4244/AIJ-D-21-00033. Epub 2022 Mar 15. AsiaIntervention. 2022. PMID: 35350791 Free PMC article.
A sham-controlled randomised trial of pulmonary artery denervation for Group 1 pulmonary arterial hypertension: one-year outcomes of the PADN-CFDA trial.
Kan J, Zhang H, Xie D, Wei Y, Zhang J, Zhang C, Yang Z, Gu H, Fan F, Gu H, Wang Q, Zhang G, Guo X, Yin Y, Wang X, Jin B, Zhou H, Yang Z, Wang Z, Xin Y, Zhang C, Meng L, Wang X, Zhao C, Yan X, Chen F, Yao C, Stone GW, Chen SL. Kan J, et al. Among authors: guo x. EuroIntervention. 2023 Oct 23;19(8):684-694. doi: 10.4244/EIJ-D-23-00349. EuroIntervention. 2023. PMID: 37458100 Free article.
Ticagrelor alone versus ticagrelor plus aspirin from month 1 to month 12 after percutaneous coronary intervention in patients with acute coronary syndromes (ULTIMATE-DAPT): a randomised, placebo-controlled, double-blind clinical trial.
Ge Z, Kan J, Gao X, Raza A, Zhang JJ, Mohydin BS, Gao F, Shao Y, Wang Y, Zeng H, Li F, Khan HS, Mengal N, Cong H, Wang M, Chen L, Wei Y, Chen F, Stone GW, Chen SL; ULTIMATE-DAPT investigators. Ge Z, et al. Lancet. 2024 Apr 5:S0140-6736(24)00473-2. doi: 10.1016/S0140-6736(24)00473-2. Online ahead of print. Lancet. 2024. PMID: 38599220
Intravascular ultrasound-guided versus angiography-guided percutaneous coronary intervention in acute coronary syndromes (IVUS-ACS): a two-stage, multicentre, randomised trial.
Li X, Ge Z, Kan J, Anjum M, Xie P, Chen X, Khan HS, Guo X, Saghir T, Chen J, Gill BUA, Guo N, Sheiban I, Raza A, Wei Y, Chen F, Mintz GS, Zhang JJ, Stone GW, Chen SL; IVUS-ACS Investigators. Li X, et al. Among authors: guo x, guo n. Lancet. 2024 Apr 5:S0140-6736(24)00282-4. doi: 10.1016/S0140-6736(24)00282-4. Online ahead of print. Lancet. 2024. PMID: 38604212
Efficacy and safety of hybutimibe in combination with atorvastatin for treatment of hypercholesteremia among patients with atherosclerotic cardiovascular disease risk equivalent: A multicenter, randomized, double-blinded phase III study.
Qi L, Chen J, Li X, Qi X, Ding C, Chen X, Gu X, Xiao W, Zhao S, Dong Y, Zheng M, Huang K, Tang L, Guo X, Wang F, Fu G, Li J, Huo Y. Qi L, et al. Among authors: guo x. Front Cardiovasc Med. 2022 Aug 16;9:888604. doi: 10.3389/fcvm.2022.888604. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36072875 Free PMC article.
Chinese Society of Cardiology guidelines on the diagnosis and treatment of adult fulminant myocarditis.
Chinese Society of Cardiology, Chinese Medical Association, Writing Group; Jiang J, Shu H, Wang DW, Hui R, Li C, Ran X, Wang H, Zhang J, Nie S, Cui G, Xiang D, Shao Q, Xu S, Zhou N, Li Y, Gao W, Chen Y, Bian Y, Wang G, Xia L, Wang Y, Zhao C, Zhang Z, Zhao Y, Wang J, Chen S, Jiang H, Chen J, Du X, Chen M, Sun Y, Li S, Ding H, Ma X, Zeng H, Lin L, Zhou S, Ma L, Tao L, Chen J, Zhou Y, Guo X. Chinese Society of Cardiology, Chinese Medical Association, Writing Group, et al. Among authors: guo x. Sci China Life Sci. 2024 May;67(5):913-939. doi: 10.1007/s11427-023-2421-0. Epub 2024 Feb 7. Sci China Life Sci. 2024. PMID: 38332216 Review.
29,769 results
You have reached the last available page of results. Please see the User Guide for more information.